Description
BSE announces the upcoming listing and admission to trading of equity shares of Corona Remedies Limited with scrip code 544644 and symbol CORONA.
Summary
BSE has informed trading members that the equity shares of Corona Remedies Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned scrip code 544644, symbol CORONA, and ISIN number INE02ZQ01018. The specific date of listing and details of the securities will be communicated through a separate notice.
Key Points
- Corona Remedies Limited equity shares to be listed on BSE
- Scrip Code: 544644
- Symbol: CORONA
- ISIN: INE02ZQ01018
- Exact listing date to be announced separately
- Notice issued by Hardik Bhuta, Assistant Vice President, BSE
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
Trading members are informed to note the upcoming listing. No specific compliance actions required at this stage. Further details including the listing date will be provided through a separate notice.
Important Dates
- Notice Date: December 12, 2025
- Listing Date: To be announced through separate notice
Impact Assessment
This is a routine listing announcement with minimal immediate market impact. The circular serves as an advance notification to trading members about the upcoming addition of Corona Remedies Limited to the BSE equity segment. Actual trading impact will occur once the specific listing date is announced and trading commences. This expands the universe of tradeable securities on BSE.
Impact Justification
Routine new listing notification with listing date to be announced separately, minimal immediate market impact